Search Count: 10
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC Ligands: NXL |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
Ligands: NXL
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC Ligands: ET5 |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
Ligands: ET5
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: 9VK, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9VK, MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VK, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VK, SO4
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-12-25 Classification: TRANSFERASE Ligands: MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: MG
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2013-12-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: LF0, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: LF0, MG